Lung Cancer Diagnostic Tests Market Report

Global and Region Lung Cancer Diagnostic Tests Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：142
  • REPORT CODE：GMM966195
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Growing prevalence of oncologic cases, constant technological advancements in diagnostics, and increasing demand for effective screening tests are some of the prime factors spurring demand for screening tools and techniques across the world. Rising awareness and supportive government initiatives are some additional factors anticipated to boost market growth during the forecast period.

    The report details the trend, potential and market size of Lung Cancer Diagnostic Tests market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Lung Cancer Diagnostic Testsmarket, defines the market attractiveness level of Lung Cancer Diagnostic Tests market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Lung Cancer Diagnostic Tests industry, describes the types of Lung Cancer Diagnostic Tests market, the applications of major players and the market size, and deeply analyzes the current situation of the global Lung Cancer Diagnostic Tests market and the development prospects and opportunities of Lung Cancer Diagnostic Tests industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Lung Cancer Diagnostic Tests market in Chapter 13.

    By Player:

    • AIT

    • Quest Diagnostics

    • Mayo Clinic

    • Biodesix

    • Emory Healthcare

    • BioMarker Strategies

    • Agilent

    • Courtagen Life Sciences Inc

    • HalioDx

    • GlycoZym

    • Epigenomics AG

    By Type:

    • Immunoassays

    • Flow Cytometry

    • Rapid Tests

    • Molecular Assays

    • Tissue Arrays

    • Circulating Tumor Cells

    • Pharmacodiagnostics

    • Biomarkers

    • Other Diagnostics Methods

    By End-User:

    • Precision Medicine

    • Personalized Medicine

    • Cancer Monitoring

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Lung Cancer Diagnostic Tests Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Lung Cancer Diagnostic Tests Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Lung Cancer Diagnostic Tests Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Lung Cancer Diagnostic Tests Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Lung Cancer Diagnostic Tests Market Analysis and Outlook to 2022

    • 7.1 Global Lung Cancer Diagnostic Tests Consumption (2017-2022)

    • 7.2 United States Lung Cancer Diagnostic Tests Consumption (2017-2022)

    • 7.3 Europe Lung Cancer Diagnostic Tests Consumption (2017-2022)

    • 7.4 China Lung Cancer Diagnostic Tests Consumption (2017-2022)

    • 7.5 Japan Lung Cancer Diagnostic Tests Consumption (2017-2022)

    • 7.6 India Lung Cancer Diagnostic Tests Consumption (2017-2022)

    • 7.7 South Korea Lung Cancer Diagnostic Tests Consumption (2017-2022)

    8 Region and Country-wise Lung Cancer Diagnostic Tests Market Analysis and Outlook to 2028

    • 8.1 Global Lung Cancer Diagnostic Tests Consumption Forecast (2022-2028)

    • 8.2 United States Lung Cancer Diagnostic Tests Consumption Forecast (2022-2028)

    • 8.3 Europe Lung Cancer Diagnostic Tests Consumption Forecast (2022-2028)

    • 8.4 China Lung Cancer Diagnostic Tests Consumption Forecast (2022-2028)

    • 8.5 Japan Lung Cancer Diagnostic Tests Consumption Forecast (2022-2028)

    • 8.6 India Lung Cancer Diagnostic Tests Consumption Forecast (2022-2028)

    • 8.7 South Korea Lung Cancer Diagnostic Tests Consumption Forecast (2022-2028)

    9 Global Lung Cancer Diagnostic Tests Market Outlook by Types and Applications to 2022

    • 9.1 Global Lung Cancer Diagnostic Tests Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Immunoassays Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Flow Cytometry Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Rapid Tests Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Molecular Assays Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Tissue Arrays Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Circulating Tumor Cells Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Pharmacodiagnostics Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Biomarkers Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Other Diagnostics Methods Consumption and Growth Rate (2017-2022)

    • 9.2 Global Lung Cancer Diagnostic Tests Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Precision Medicine Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Personalized Medicine Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cancer Monitoring Consumption and Growth Rate (2017-2022)

    10 Global Lung Cancer Diagnostic Tests Market Outlook by Types and Applications to 2028

    • 10.1 Global Lung Cancer Diagnostic Tests Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Immunoassays Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Flow Cytometry Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Rapid Tests Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Molecular Assays Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Tissue Arrays Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Circulating Tumor Cells Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Pharmacodiagnostics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Biomarkers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.9 Global Other Diagnostics Methods Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Lung Cancer Diagnostic Tests Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Precision Medicine Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cancer Monitoring Consumption Forecast and Growth Rate (2022-2028)

    11 Global Lung Cancer Diagnostic Tests Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Lung Cancer Diagnostic Tests Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Lung Cancer Diagnostic Tests Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Lung Cancer Diagnostic Tests Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Lung Cancer Diagnostic Tests Market Competitive Analysis

    • 14.1 AIT

      • 14.1.1 AIT Company Details

      • 14.1.2 AIT Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AIT Lung Cancer Diagnostic Tests Product and Service

    • 14.2 Quest Diagnostics

      • 14.2.1 Quest Diagnostics Company Details

      • 14.2.2 Quest Diagnostics Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Quest Diagnostics Lung Cancer Diagnostic Tests Product and Service

    • 14.3 Mayo Clinic

      • 14.3.1 Mayo Clinic Company Details

      • 14.3.2 Mayo Clinic Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Mayo Clinic Lung Cancer Diagnostic Tests Product and Service

    • 14.4 Biodesix

      • 14.4.1 Biodesix Company Details

      • 14.4.2 Biodesix Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Biodesix Lung Cancer Diagnostic Tests Product and Service

    • 14.5 Emory Healthcare

      • 14.5.1 Emory Healthcare Company Details

      • 14.5.2 Emory Healthcare Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Emory Healthcare Lung Cancer Diagnostic Tests Product and Service

    • 14.6 BioMarker Strategies

      • 14.6.1 BioMarker Strategies Company Details

      • 14.6.2 BioMarker Strategies Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 BioMarker Strategies Lung Cancer Diagnostic Tests Product and Service

    • 14.7 Agilent

      • 14.7.1 Agilent Company Details

      • 14.7.2 Agilent Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Agilent Lung Cancer Diagnostic Tests Product and Service

    • 14.8 Courtagen Life Sciences Inc

      • 14.8.1 Courtagen Life Sciences Inc Company Details

      • 14.8.2 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product and Service

    • 14.9 HalioDx

      • 14.9.1 HalioDx Company Details

      • 14.9.2 HalioDx Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 HalioDx Lung Cancer Diagnostic Tests Product and Service

    • 14.10 GlycoZym

      • 14.10.1 GlycoZym Company Details

      • 14.10.2 GlycoZym Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 GlycoZym Lung Cancer Diagnostic Tests Product and Service

    • 14.11 Epigenomics AG

      • 14.11.1 Epigenomics AG Company Details

      • 14.11.2 Epigenomics AG Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Epigenomics AG Lung Cancer Diagnostic Tests Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Lung Cancer Diagnostic Tests

    • Figure Lung Cancer Diagnostic Tests Picture

    • Table Global Lung Cancer Diagnostic Tests Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Lung Cancer Diagnostic Tests Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Lung Cancer Diagnostic Tests Consumption by Country (2017-2022)

    • Figure United States Lung Cancer Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Table Europe Lung Cancer Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure China Lung Cancer Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Japan Lung Cancer Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure India Lung Cancer Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure South Korea Lung Cancer Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Diagnostic Tests Consumption Forecast by Country (2022-2028)

    • Figure United States Lung Cancer Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Lung Cancer Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Lung Cancer Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Lung Cancer Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Lung Cancer Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Lung Cancer Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunoassays Consumption and Growth Rate (2017-2022)

    • Figure Global Flow Cytometry Consumption and Growth Rate (2017-2022)

    • Figure Global Rapid Tests Consumption and Growth Rate (2017-2022)

    • Figure Global Molecular Assays Consumption and Growth Rate (2017-2022)

    • Figure Global Tissue Arrays Consumption and Growth Rate (2017-2022)

    • Figure Global Circulating Tumor Cells Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacodiagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Biomarkers Consumption and Growth Rate (2017-2022)

    • Figure Global Other Diagnostics Methods Consumption and Growth Rate (2017-2022)

    • Figure Global Precision Medicine Consumption and Growth Rate (2017-2022)

    • Figure Global Personalized Medicine Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Monitoring Consumption and Growth Rate (2017-2022)

    • Figure Global Immunoassays Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Flow Cytometry Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rapid Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Molecular Assays Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tissue Arrays Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Circulating Tumor Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacodiagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biomarkers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Diagnostics Methods Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Precision Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Personalized Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Monitoring Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Lung Cancer Diagnostic Tests Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Lung Cancer Diagnostic Tests Export by Region (Top 5 Countries) (2017-2028)

    • Table AIT (Foundation Year, Company Profile and etc.)

    • Table AIT Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table AIT Lung Cancer Diagnostic Tests Product and Service

    • Table Quest Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Quest Diagnostics Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quest Diagnostics Lung Cancer Diagnostic Tests Product and Service

    • Table Mayo Clinic (Foundation Year, Company Profile and etc.)

    • Table Mayo Clinic Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mayo Clinic Lung Cancer Diagnostic Tests Product and Service

    • Table Biodesix (Foundation Year, Company Profile and etc.)

    • Table Biodesix Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biodesix Lung Cancer Diagnostic Tests Product and Service

    • Table Emory Healthcare (Foundation Year, Company Profile and etc.)

    • Table Emory Healthcare Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emory Healthcare Lung Cancer Diagnostic Tests Product and Service

    • Table BioMarker Strategies (Foundation Year, Company Profile and etc.)

    • Table BioMarker Strategies Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMarker Strategies Lung Cancer Diagnostic Tests Product and Service

    • Table Agilent (Foundation Year, Company Profile and etc.)

    • Table Agilent Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Lung Cancer Diagnostic Tests Product and Service

    • Table Courtagen Life Sciences Inc (Foundation Year, Company Profile and etc.)

    • Table Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product and Service

    • Table HalioDx (Foundation Year, Company Profile and etc.)

    • Table HalioDx Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table HalioDx Lung Cancer Diagnostic Tests Product and Service

    • Table GlycoZym (Foundation Year, Company Profile and etc.)

    • Table GlycoZym Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlycoZym Lung Cancer Diagnostic Tests Product and Service

    • Table Epigenomics AG (Foundation Year, Company Profile and etc.)

    • Table Epigenomics AG Lung Cancer Diagnostic Tests Sales, Price, Value and Gross Profit (2017-2022)

    • Table Epigenomics AG Lung Cancer Diagnostic Tests Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US